Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 84.54%589.37K | 54.38%83.6K | -55.63%74.17K | 100.68%116.8K | 689.68%314.81K | 213.80%319.36K | 1.75%54.15K | 36,475.93%167.15K | 113.60%58.2K | 91.18%39.87K |
| Selling and administrative expenses | 87.50%573.15K | 61.44%79.8K | -57.22%71.51K | 100.68%116.8K | 886.58%304.88K | 242.50%305.68K | -5.56%49.43K | 35,364.14%167.15K | 119.40%58.2K | 173.94%30.9K |
| -General and administrative expense | 87.50%573.15K | 61.44%79.8K | -57.22%71.51K | 100.68%116.8K | 886.58%304.88K | 242.50%305.68K | -5.56%49.43K | 35,364.14%167.15K | 119.40%58.2K | 173.94%30.9K |
| Other operating expenses | 18.55%16.22K | -19.55%3.8K | --2.66K | ---- | 10.72%9.92K | 9.24%13.68K | 439.09%4.72K | ---- | ---- | -6.36%8.96K |
| Operating profit | -84.54%-589.37K | -54.38%-83.6K | 55.63%-74.17K | -100.68%-116.8K | -689.68%-314.81K | -213.80%-319.36K | -1.75%-54.15K | -36,475.93%-167.15K | -113.60%-58.2K | -91.18%-39.87K |
| Net non-operating interest income (expenses) | -36.96%147.99K | -51.24%21.08K | -33.33%42.03K | -33.84%42.6K | -33.38%42.7K | 3.77%234.75K | -34.09%43.23K | 3.87%63.04K | 26.20%64.39K | 31.00%64.09K |
| Non-operating interest income | -36.96%147.99K | -51.24%21.08K | -33.33%42.03K | -33.84%42.6K | -33.38%42.7K | 3.77%234.75K | -34.09%43.23K | 3.87%63.04K | 26.20%64.39K | 31.00%64.09K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -411.34%-427.4K | -390.84%-49.11K | 69.18%-32.06K | -1,298.13%-74.13K | -1,223.05%-272.1K | -167.16%-83.59K | -180.88%-10.01K | -272.65%-104K | -73.97%6.19K | -13.70%24.23K |
| Income tax | ||||||||||
| Net income | -411.34%-427.4K | -390.84%-49.11K | 69.18%-32.06K | -1,298.13%-74.13K | -1,223.05%-272.1K | -167.16%-83.59K | -180.88%-10.01K | -272.65%-104K | -73.97%6.19K | -13.70%24.23K |
| Net income continuous operations | -411.34%-427.4K | -390.84%-49.11K | 69.18%-32.06K | -1,298.13%-74.13K | -1,223.05%-272.1K | -167.16%-83.59K | -180.88%-10.01K | -272.65%-104K | -73.97%6.19K | -13.70%24.23K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -411.34%-427.4K | -390.84%-49.11K | 69.18%-32.06K | -1,298.13%-74.13K | -1,223.05%-272.1K | -167.16%-83.59K | -180.88%-10.01K | -272.65%-104K | -73.97%6.19K | -13.70%24.23K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -411.34%-427.4K | -390.84%-49.11K | 69.18%-32.06K | -1,298.13%-74.13K | -1,223.05%-272.1K | -167.16%-83.59K | -180.88%-10.01K | -272.65%-104K | -73.97%6.19K | -13.70%24.23K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -0.01 | 0 | 0 | 0 | -0.01 | 0 | 0 | 0 | 0 | 0 |
| Diluted earnings per share | -0.01 | 0 | 0 | 0 | -0.01 | 0 | 0 | 0 | 0 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.